Drug Supply Chain Security Act

The Drug Supply Chain Security Act (DSCSA),  aims to protect the product and the patient by meanings of the following: 

  • Enhance the ability to help and protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful
  • Improve detection and removal of potentially dangerous drugs from the drug supply chain

All the pharmaceutical stakeholders, both manufacturers and trading partners (re-packagers, distributors, wholesalers, and dispensers), will be required to have a secure interoperable track and trace solution in place to build a complete interoperable electronic system for tracking and identifying prescription drugs on sale in the US. 

With the new requirements established by DSCSA, wholesalers and dispensers are required to implement interoperable and electronic tracing of products at the package level, exchanging data (product tracing information, TI and TS) between themselves.  Additionally, if the distributors would like to resell a returned product, the manufacturer should be able to receive electronically a query to which respond promptly. 

This can happen using systems that are fully capable to trace and verify the distributed products across the pharmaceutical distribution supply chain.